Loading…
Based on limited metadata, Bonagens received an FDA Warning Letter on November 17, 2020, regarding dietary supplement products. While the specific violations cannot be detailed without access to the full letter text, the warning indicates regulatory concerns with the company's dietary supplement operations. The FDA's issuance of this warning letter establishes that Bonagens' products or manufacturing practices did not meet federal dietary supplement requirements under FDA oversight.